ArticleScientific reports2025
Cervical cancer screening utilization and associated factors among women living with HIV in South West Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is a public health challenge among reproductive-age women in low and middle-income countries (LMICs). Primarily cervical cancer affects vulnerable group of HIV-positive women more than others. Despite overwhelming evidence that cervical cancer screening reduces maternal morbidity and mortality, there is limited study on the utilization of cervical cancer screening among HIV-positive women in Ethiopia. Therefore this study was conducted to assess the utilization and associated factors of cervical cancer screening among HIV- positive women in south west Ethiopia. A facility-based cross-sectional study was conducted among 387 HIV-positive women from July to August 2021. Data was collected through face-to-face interviews and checklists. After data were checked, it was entered into Epi-Data version 3.1 and then exported to SPSS version 23 for statistical analysis. Logistic regression was used to investigate the relationship between dependent and independent variables. The association was reported using the adjusted odds ratio (AOR) with a 95% confidence interval (CI), and the level of statistical significance was declared with a P-value less than 0.05. The study revealed that 41.3%; (95% CI: 36.6-46.6) of HIV-positive women underwent cervical cancer screening. More than half (57.6%) of study participant' had heard about cervical cancer screening. Having multiple sexual partners (AOR = 3.13; 95%CI: 1.79-5.47), having a CD4 count less than 500cells/mm3 (AOR = 2.05; 95%CI: 1.29-2.23) and ever hearing about premalignant cervical cancer (AOR = 2.13; 95% CI: 1.35-3.37) were independent predictors of cervical cancer screening utilization among HIV- positive women. The study found that utilization of cervical cancer screenings among HIV-positive was relatively low. Those who have multiple sexual partners, aCD4 count less than 500cell/mm3 and have ever heard about premalignant cervical cancer were more likely use cervical cancer screening. All concerned bodies should improve awareness to increase utilization and integrating the cervical cancer screening services with ART clinics in all settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.